Research Article
N-Acetyltransferase 10 Enhances Doxorubicin Resistance in Human Hepatocellular Carcinoma Cell Lines by Promoting the Epithelial-to-Mesenchymal Transition
Figure 1
Inhibition of NAT10 using remodelin increases the chemosensitivity of HCC cell lines to doxorubicin. (a–d) CCK-8 assay of cell viability. (e–h) Representative images and quantification of EdU incorporation assay of cell growth and DNA synthesis. , doxorubicin vs. control cells; , doxorubicin+remodelin vs. remodelin.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |